FDA Investigator Meocha V Whaley
Meocha V Whaley has conducted inspections on 24 sites in 1 countries as of 28 Mar 2024. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
24
Last Inspection Date:
28 Mar 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Meocha V Whaley:
Ann B Borromeo,
Ashley N Jeans,
Benjamin E Bowen,
Bonnie E Conley,
Bonnie E Pierson,
Brandon C Heitmeier,
Caitlin L Almonrode,
Charlie Woodson,
Cherie T Parker,
Cheryl G Scott,
Cheryl L Watson,
Christopher J Adams,
Clendening,
Combs,
Cynthia L Medlin,
David P Vanhouten,
Demario L Walls,
Edward H Maticka,
Emily E Smith,
Erica M Katherine,
Erica N Sandoval,
Francis A Guidry,
George J Flynn,
Jonathan A Ferguson,
Josiah D Davis,
June P Page,
Justin N Henson,
Kenneth R Merritt,
Kerry Ann Latham,
Kimberly J Hoffmeister,
Kimberly L Mcmillan,
Kip J Hanks,
Krista B Jones,
Krista W Whitten,
Lacey J Chessor,
Laura L Staples,
Linda A Gregory Duty,
Lynn Moore,
Maressa L Mills,
Margaret E Slimbach,
Marie F Morin,
Markeesa M Scales,
Marshall H Kinsey,
Marvin D Jones,
Mary A Millner,
Melanie L Drayton,
Pamela M Thomas,
Robert E Hultman,
Samantha J Bradley,
Sandy L Atkins,
Saundrea A Munroe,
Shelton L Stribling,
Steven D Dittert,
Thomas B Smith,
Thomas O Morgan,
Thomas R Stanley,
Travis E Chapman,
Whitney M White,
Zada L Giles
Meocha V Whaley's Documents
Publish Date | Document Type | Title |
---|---|---|
November, 2016 | FDA 483 | Preferred Medical Products Inc - Form 483, 2016-11-03 |
June, 2016 | FDA 483 | Green Hills Health and Wellness Pharmacy Inc - Form 483, 2016-06-30 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more